13F
中

ACRV ACRIVON THERAPEUTICS INC

2026Q1 · CUSIP 004890109 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
43
Δ holders QoQ
-5
Breadth percentile
Top 78%
Whale holders
25
Δ whales
-3
Inst. holding value
$23M
New positions
10
Closed positions
15
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2023Q1: Δ+19 · h=38 2023Q2: Δ+3 · h=41 2023Q3: Δ+3 · h=44 2023Q4: Δ-1 · h=43 2024Q1: Δ+6 · h=49 2024Q2: Δ+7 · h=56 2024Q3: Δ+0 · h=56 2024Q4: Δ+8 · h=64 2025Q1: Δ+0 · h=64 2025Q2: Δ-10 · h=54 2025Q3: Δ-6 · h=48 2025Q4: Δ+0 · h=48 2026Q1: Δ-5 · h=43 2023Q1: holders=38 2023Q2: holders=41 2023Q3: holders=44 2023Q4: holders=43 2024Q1: holders=49 2024Q2: holders=56 2024Q3: holders=56 2024Q4: holders=64 2025Q1: holders=64 2025Q2: holders=54 2025Q3: holders=48 2025Q4: holders=48 2026Q1: holders=43 -19 -9.5 +0 +9.5 +19 345168 23Q123Q223Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2023Q1 Top 8% -18.2% -61.6%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.00
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2023-03-31: EPS -0.58 2023-06-30: EPS -0.63 2023-09-30: EPS -0.66 2023-12-31: EPS -0.87 2024-03-31: EPS -0.73 2024-06-30: EPS -0.52 2024-09-30: EPS -0.59 2024-12-31: EPS -0.54 2025-03-31: EPS -0.51 2025-06-30: EPS -0.55 2025-09-30: EPS -0.47 2025-12-31: EPS -0.49 2026-03-31: EPS -0.49 -0.96 -0.48 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)